Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UNC13B, also known as Protein unc-13 homolog B (Munc13-2), is a multidomain presynaptic active zone protein required for synaptic vesicle priming and effective neurotransmitter release. Highly expressed in the brain, especially the cerebral cortex, and in other tissues including kidney and eye, UNC13B interacts with diacylglycerol and calmodulin, and contains multiple C2 domains and a DAG-binding C1 domain. Hyperglycemia can upregulate its expression and induce apoptosis in kidney cells. In the nervous system, UNC13B orchestrates the assembly and positioning of synaptic vesicles, controls the location and efficiency of vesicle release, and enables fast, reliable neurotransmission by facilitating the fusion of vesicles with the neuronal membrane. It is distinct from the closely related UNC13A, contributing uniquely to neural information processing, such as olfactory decoding, and its dysfunction or altered expression has been implicated in several neurologic and renal diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein unc-13 homolog B (UNC13B).